Biotechnology

Seegene introduces a High-throughput 8-plex Test for Flu A, Flu B, RSV and COVID-19 with dual internal controls

SEOUL, South Korea, Sept. 8, 2020 /PRNewswire/ -- Seegene, Inc. introduced a single tube real-time RT-PCR assay, Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay, which simultaneously detects and differentiates Flu A, Flu B, RSV A/B, and three different target genes of COVID-19 (S gene, RdRP gene and N ge...

2020-09-08 20:00 2449

Seegene introduces a High-throughput 8-plex Test for Flu A, Flu B, RSV and COVID-19 with dual internal controls

SEOUL, South Korea, Sept. 8, 2020 /PRNewswire/ -- Seegene, Inc. introduced a single tube real-time RT-PCR assay, Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay, which simultaneously detects and differentiates Flu A, Flu B, RSV A/B, and three different target genes of COVID-19 (S gene, RdRP gene and N ge...

2020-09-08 20:00 3097

Life After Covid-19: Big Questions on Medical and Bio-Engineering

DAEJEON, South Korea, Sept. 8, 2020 /PRNewswire/ -- On September 9, the Global Strategic Institute at KAIST will delve into innovative future strategies for the medical and bio-engineering sectors that have been disrupted by COVID-19. The forum will live stream via YouTube, KTV, and Naver TV from...

2020-09-08 15:52 2021

Transcenta Holding Announces Appointment of Dr. Charlie Qi as Senior Vice President of Global Clinical Development

SUZHOU, China, Sept.7, 2020 /PRNewswire/ -- Transcenta Holding Limited (Transcenta), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced the appointment of Dr.Charlie Qi as its Senior Vice...

2020-09-07 23:00 1707

Ascentage Pharma's Bcl-2 Inhibitor APG-2575 Granted Orphan Drug Designation by the FDA for the Treatment of Chronic Lymphocytic Leukemia

SUZHOU, China and ROCKVILLE, Md., Sept. 7, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug A...

2020-09-07 17:16 2617

Polygiene ViralOff proven effective against SARS-CoV-2

STOCKHOLM, Sept. 7, 2020 /PRNewswire/ -- In the first test ever using the ISO method* on the SARS-CoV-2 virus on textiles, Polygiene ViralOff® was confirmed the first commercial textiles treatment in the world to reduce the virus by over 99% over two hours. While this comes as no surprise to us, ...

2020-09-07 14:23 2724

RhoVac appoints Professor Georg Hollaender to its Scientific Advisory Board

STOCKHOLM, Sept. 4, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today September 4th 2020,  that it is continuing to strengthen the Scientific Advisory Board with a pediatric immunologist, by appointing ProfessorGeorg Hollaender, Action Research Professor and Head of Department at Oxford ...

2020-09-04 17:35 3885

Concept Medical announces enrolment of index patient in the crucial Transform -1 RCT using MagicTouch sirolimus coated balloon for small coronary vessels

COTIGNOLA, Italy, Sept. 3, 2020 /PRNewswire/ -- Concept Medical Inc ., focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in the TRANSFORM-1

2020-09-03 00:55 4192

George Clinical Adds CRO Business Development and Operations Veteran to Lead Efforts in China

OVERLAND PARK, Kansas, Sept. 3, 2020 /PRNewswire/ -- George Clinical, a global scientifically-backed clinical research organization, has expanded the organization's team inChina with the addition of Dr. Zhenfei Yin in the role of Country Head and Regional Head of Project Operations.  Zhenfei will...

2020-09-03 00:00 3534

PharmAbcine is presenting at the KSMO 2020

DAEJEON, South Korea, Sept. 2, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotechnology company in South Korea, announced today that onSeptember 4th, the company will present the interim data of its ongoing IO combo clinical trials at KSMO 2020. KSMO 2020 is the...

2020-09-02 21:00 2072

PharmAbcine signs a CMO contract with Binex so Binex can produce olinvacimab at its new 5,000L production line

DAEJEON, South Korea, Sept. 2, 2020 /PRNewswire/ -- PharmAbcine (KRX: 208340ks), a biotech company focusing on the development of antibody therapeutics, announcedon August 31 that it had signed a contract manufacturing organization(CMO) agreement with Binex, a leading biologics CDMO(Contract Dev...

2020-09-02 21:00 1965

Clene Nanomedicine, Inc. to go Public through Merger with Tottenham Acquisition I Limited

* Clene is a clinical-stage biopharmaceutical company developing the first potential therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neur...

2020-09-02 20:00 18848

BOI Says Investors Show Increasing Interest in Thailand's Medical Sector

BANGKOK, Sept. 2, 2020 /PRNewswire/ -- A growing number of international and Thai companies are investing inThailand's medical to help address the COVID-19 situation as well as to build on the country's potential as a medical hub, the Thailand's Board of Investment (BOI) said.

2020-09-02 17:35 4739

bitBiome has raised 700 million JPY in Seed financing

TOKYO, Sept. 1, 2020 /PRNewswire/ -- bitBiome, Inc., an emerging leader in microbiome analytics, has raised700 million JPY (approx. $6.6m US) in seed financing from previous and new investors including TheUniversity of Tokyo Edge Capital Partners, Universal Materials Incubator, and otherJapan-ba...

2020-09-02 11:28 1910

Humoral immune response to SARS-CoV2 in Iceland

Titers of antibodies against SARS-CoV2 do not decline within four months REYKJAVIK, Iceland, Sept. 2, 2020 /PRNewswire/ -- Scientists at deCODE genetics inIceland, a subsidiary of Amgen Inc , biopharmaceutical company headquartered inCalifornia, and their collaborators, today publish a study in ...

2020-09-02 05:00 3531

Ortho Announces Board of Director Appointments

Noted Diagnostic Industry Veteran David B. Perez Joins as an Independent Director Chris Smith Appointed Chairman of the Board, in addition to current CEO role RARITAN, N.J., Sept. 2, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced thatDav...

2020-09-02 04:51 2212

Bridgewest Australia Holdings LLC Acquires Pfizer manufacturing facility in Adelaide, Australia

Bridgewest to develop the site into a full-service Contract Development and Manufacturing Organization SAN DIEGO and ADELAIDE, Australia, Sept. 2, 2020 /PRNewswire/ -- The Bridgewest Group, a premier private investment company that focuses on disrupting industries through innovation today announ...

2020-09-02 01:01 5166

Aqua Medical Announces Final $8.2 Million Equity Investment Led by ShangBay Capital to Close Its $15.5 Million Series A Financing Round

Investment will be used to advance its novel vapor-based ablation system to treat precancerous conditions and metabolic disease such as type 2 diabetes in the gastrointestinal (GI) tract. SANTA ANA, California, Sept. 1, 2020 /PRNewswire/ -- Aqua Medical's innovative platform technology provides ...

2020-09-01 22:00 2508

Visiopharm raises fresh capital with BankInvest as lead investor

COPENHAGEN, Denmark, Sept. 1, 2020 /PRNewswire/ -- In a new investment round, Visiopharm added BankInvest to the group of institutional investors that already includes ATP, NorthCap, Vækstfonden, and C.L. Davids Fond. BankInvest now holds almost 6% of the equity of the company. All existing inves...

2020-09-01 14:00 2080

GEN inCode Announces Completion of £3M Institutional Foundation Fundraise

OXFORD, England, Sept. 1, 2020 /PRNewswire/ -- GEN inCode UK Limited, the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease, announces today the completion of a £3.0M institutional fundraise to internationally scale its prod...

2020-09-01 14:00 2230
1 ... 277278279280281282283 ... 306